Cargando…

Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study

BACKGROUND: Glioblastomas are mostly resected under general anesthesia under the supervision of a general anesthesiologist. Currently, it is largely unkown if clinical outcomes of GBM patients can be improved by appointing a neuro-anesthesiologist for their cases. We aimed to evaluate whether the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerritsen, Jasper Kees Wim, Rizopoulos, Dimitris, Schouten, Joost Willem, Haitsma, Iain Kristian, Eralp, Ismail, Klimek, Markus, Dirven, Clemens Maria Franciscus, Vincent, Arnaud Jean Pierre Edouard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746943/
https://www.ncbi.nlm.nih.gov/pubmed/36512593
http://dx.doi.org/10.1371/journal.pone.0278864
_version_ 1784849477149917184
author Gerritsen, Jasper Kees Wim
Rizopoulos, Dimitris
Schouten, Joost Willem
Haitsma, Iain Kristian
Eralp, Ismail
Klimek, Markus
Dirven, Clemens Maria Franciscus
Vincent, Arnaud Jean Pierre Edouard
author_facet Gerritsen, Jasper Kees Wim
Rizopoulos, Dimitris
Schouten, Joost Willem
Haitsma, Iain Kristian
Eralp, Ismail
Klimek, Markus
Dirven, Clemens Maria Franciscus
Vincent, Arnaud Jean Pierre Edouard
author_sort Gerritsen, Jasper Kees Wim
collection PubMed
description BACKGROUND: Glioblastomas are mostly resected under general anesthesia under the supervision of a general anesthesiologist. Currently, it is largely unkown if clinical outcomes of GBM patients can be improved by appointing a neuro-anesthesiologist for their cases. We aimed to evaluate whether the assignment of dedicated neuro-anesthesiologists improves the outcomes of these patients. We also investigated the value of dedicated neuro-oncological surgical teams as an independent variable in both groups. METHODS: A cohort consisting of 401 GBM patients who had undergone resection was retrospectively investigated. Primary outcomes were postoperative neurological complications, fluid balance, length-of-stay and overall survival. Secondary outcomes were blood loss, anesthesia modality, extent of resection, total admission costs, and duration of surgery. RESULTS: 320 versus 81 patients were operated under the anesthesiological supervision of a general anesthesiologist and a dedicated neuro-anesthesiologist, respectively. Dedicated neuro-anesthesiologists yielded significant superior outcomes in 1) postoperative neurological complications (early: p = 0.002, OR = 2.54; late: p = 0.003, OR = 2.24); 2) fluid balance (p<0.0001); 3) length-of-stay (p = 0.0006) and 4) total admission costs (p = 0.0006). In a subanalysis of the GBM resections performed by an oncological neurosurgeon (n = 231), the assignment of a dedicated neuro-anesthesiologist independently improved postoperative neurological complications (early minor: p = 0.0162; early major: p = 0.00780; late minor: p = 0.00250; late major: p = 0.0364). The assignment of a dedicated neuro-oncological team improved extent of resection additionally (p = 0.0416). CONCLUSION: GBM resections with anesthesiological supervision of a dedicated neuro-anesthesiologists are associated with improved patient outcomes. Prospective evidence is needed to further investigate the usefulness of the dedicated neuro-anesthesiologist in different settings.
format Online
Article
Text
id pubmed-9746943
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-97469432022-12-14 Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study Gerritsen, Jasper Kees Wim Rizopoulos, Dimitris Schouten, Joost Willem Haitsma, Iain Kristian Eralp, Ismail Klimek, Markus Dirven, Clemens Maria Franciscus Vincent, Arnaud Jean Pierre Edouard PLoS One Research Article BACKGROUND: Glioblastomas are mostly resected under general anesthesia under the supervision of a general anesthesiologist. Currently, it is largely unkown if clinical outcomes of GBM patients can be improved by appointing a neuro-anesthesiologist for their cases. We aimed to evaluate whether the assignment of dedicated neuro-anesthesiologists improves the outcomes of these patients. We also investigated the value of dedicated neuro-oncological surgical teams as an independent variable in both groups. METHODS: A cohort consisting of 401 GBM patients who had undergone resection was retrospectively investigated. Primary outcomes were postoperative neurological complications, fluid balance, length-of-stay and overall survival. Secondary outcomes were blood loss, anesthesia modality, extent of resection, total admission costs, and duration of surgery. RESULTS: 320 versus 81 patients were operated under the anesthesiological supervision of a general anesthesiologist and a dedicated neuro-anesthesiologist, respectively. Dedicated neuro-anesthesiologists yielded significant superior outcomes in 1) postoperative neurological complications (early: p = 0.002, OR = 2.54; late: p = 0.003, OR = 2.24); 2) fluid balance (p<0.0001); 3) length-of-stay (p = 0.0006) and 4) total admission costs (p = 0.0006). In a subanalysis of the GBM resections performed by an oncological neurosurgeon (n = 231), the assignment of a dedicated neuro-anesthesiologist independently improved postoperative neurological complications (early minor: p = 0.0162; early major: p = 0.00780; late minor: p = 0.00250; late major: p = 0.0364). The assignment of a dedicated neuro-oncological team improved extent of resection additionally (p = 0.0416). CONCLUSION: GBM resections with anesthesiological supervision of a dedicated neuro-anesthesiologists are associated with improved patient outcomes. Prospective evidence is needed to further investigate the usefulness of the dedicated neuro-anesthesiologist in different settings. Public Library of Science 2022-12-13 /pmc/articles/PMC9746943/ /pubmed/36512593 http://dx.doi.org/10.1371/journal.pone.0278864 Text en © 2022 Gerritsen et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Gerritsen, Jasper Kees Wim
Rizopoulos, Dimitris
Schouten, Joost Willem
Haitsma, Iain Kristian
Eralp, Ismail
Klimek, Markus
Dirven, Clemens Maria Franciscus
Vincent, Arnaud Jean Pierre Edouard
Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study
title Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study
title_full Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study
title_fullStr Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study
title_full_unstemmed Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study
title_short Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study
title_sort impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: a single-institution cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746943/
https://www.ncbi.nlm.nih.gov/pubmed/36512593
http://dx.doi.org/10.1371/journal.pone.0278864
work_keys_str_mv AT gerritsenjasperkeeswim impactofdedicatedneuroanesthesiamanagementonclinicaloutcomesinglioblastomapatientsasingleinstitutioncohortstudy
AT rizopoulosdimitris impactofdedicatedneuroanesthesiamanagementonclinicaloutcomesinglioblastomapatientsasingleinstitutioncohortstudy
AT schoutenjoostwillem impactofdedicatedneuroanesthesiamanagementonclinicaloutcomesinglioblastomapatientsasingleinstitutioncohortstudy
AT haitsmaiainkristian impactofdedicatedneuroanesthesiamanagementonclinicaloutcomesinglioblastomapatientsasingleinstitutioncohortstudy
AT eralpismail impactofdedicatedneuroanesthesiamanagementonclinicaloutcomesinglioblastomapatientsasingleinstitutioncohortstudy
AT klimekmarkus impactofdedicatedneuroanesthesiamanagementonclinicaloutcomesinglioblastomapatientsasingleinstitutioncohortstudy
AT dirvenclemensmariafranciscus impactofdedicatedneuroanesthesiamanagementonclinicaloutcomesinglioblastomapatientsasingleinstitutioncohortstudy
AT vincentarnaudjeanpierreedouard impactofdedicatedneuroanesthesiamanagementonclinicaloutcomesinglioblastomapatientsasingleinstitutioncohortstudy